 | • レポートコード：B-MOR-08470 • 出版社/出版日：Mordor Intelligence / 2018年6月22日 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、プレフィルドシリンジ（薬剤充填済み注射器）の世界市場について調べ、プレフィルドシリンジ（薬剤充填済み注射器）の世界規模、市場動向、市場環境、材料別（ガラス、プラスチック）分析、用途別（糖尿病、アナフィラキシー、関節炎、ワクチン、その他）分析、種類別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場インサイト ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場環境 ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場動向 ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場規模 ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場規模：材料別（ガラス、プラスチック） ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場規模：用途別（糖尿病、アナフィラキシー、関節炎、ワクチン、その他） ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場規模：種類別 ・プレフィルドシリンジ（薬剤充填済み注射器）の世界市場：地域別市場規模・分析 ・プレフィルドシリンジ（薬剤充填済み注射器）の北米市場規模・予測 ・プレフィルドシリンジ（薬剤充填済み注射器）のアメリカ市場規模・予測 ・プレフィルドシリンジ（薬剤充填済み注射器）のヨーロッパ市場規模・予測 ・プレフィルドシリンジ（薬剤充填済み注射器）のアジア市場規模・予測 ・プレフィルドシリンジ（薬剤充填済み注射器）の日本市場規模・予測 ・プレフィルドシリンジ（薬剤充填済み注射器）の中国市場規模・予測 ・プレフィルドシリンジ（薬剤充填済み注射器）のインド市場規模・予測 ・プレフィルドシリンジ（薬剤充填済み注射器）の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global prefilled syringes market is expected to register a growth rate of CAGR of 10.5% during the forecast period, 2018-2023. Prefilled syringes provide an easier way to perform drug delivery through injection as compared to traditional ways. In addition to this, it saves time and efforts of healthcare practitioners. It also reduces the wastage of active pharmaceutical ingredients (API). The demand for prefilled syringes is rising due to increase in patient safety and efforts of healthcare professionals to reduce the hospital errors. Europe market is expected to have largest market share owing to increase in adoption of self-care devices and presence of major key players in the region.
Benefits Associated with Prefilled Syringes
The prefilled syringes make injections easier and safer to patients as well as doctors and it can deliver the right amount of the dosage. In addition, pharmaceutical companies can get benefit by saving the cost of vials. The prefilled syringes work well with safety devices and auto-injection systems. The Centers for Disease Control and Prevention strongly encourages the use of single dose rather than multi-dose vials, in order to reduce the contamination. These aforementioned benefits associated with prefilled syringes are expected to propel the growth of this market.
Other factors, such as rising adoption of self-care devices and increase in use of prefilled syringes for biologics, are expected to drive the growth of the market over the forecasted period.
Product Recalls
The stringent regulation policies of US FDA and serious product defects are the major reasons of product recalls in medical devices industry. The medical devices are mainly classified into three different types, as per their cause of serious health problems (low, moderate, and severe). The actual reasons for the recall of the product vary by therapeutic area. The post-market issues are more than pre-market issues. Post-market issues include manufacturing issues, software manufacturing issues, supplier issues, sterilization, and labeling errors. These factors affect the image of these products and hence the perception of user and healthcare providers toward the products. These factors will be detrimental to the growth of prefilled syringe market and will act as a restraint for the growth of the market over the forecasted period.
Other factors that will act as restraints for the market include the availability of alternate drug-delivery methods.
Europe to Dominate this Market
The European market of prefilled syringes is more mature than the US market. Europe is expected to capture the largest market share over the forecasted period owing to increase in adoption of self-care devices market. As the demand for prefilled syringes has increased, manufacturers have had to, respond to increasing demand, new requirements, and more sophisticated forms of drug delivery. There are huge R&D going on this product to fulfill the need of the customers. The new products are being added to the prefilled syringes. Vaccines, blood stimulants, therapeutic proteins, erythroproteins, interferons, and rheumatoid arthritis.
Key Developments in the Market
• July 2017 – Gerresheimer will complete its product portfolio of prefillable syringes made of glass and plastics with an innovative, integrated, passive syringe safety solution, acquired through an exclusive licence from West Pharmaceutical Services Inc.
Major Players – BECTON, DICKINSON AND COMPANY, GERRESHEIMER AG, HASELMEIER AG, MEDTRONIC, NIPRO, SCANDINAVIAN HEALTH LIMITED (SHL GROUP), SCHOTT, STEVANATO GROUP, TERUMO CORPORATION, and UNILIFE CORPORATION amongst others.
Reasons to Purchase this Report
• The current and future global outlook of the prefilled syringes market in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• Information on the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identification of the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Pipeline Analysis
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Consumers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitute Product and Services
5.3.5 Competitive Rivalry within the Industry
5.4 Regulatory Screnario
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Adoption of Self-care Devices
6.1.2 Benefits Associated With Prefilled Syringes
6.1.3 Increase in Use of Prefilled Syringes for Biologics
6.2 Market Restraints
6.2.1 Product Recalls
6.2.2 Availability of Alternate Drug-delivery Methods
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Material
7.1.1 Glass Prefilled Syringes
7.1.2 Plastic Prefilled Syringes
7.2 By Application
7.2.1 Diabetes
7.2.2 Anaphylaxis
7.2.3 Arthritis
7.2.4 Vaccine
7.2.5 Others
7.3 By Type
7.3.1 Disposable Prefilled Syringes
7.3.2 Reusable Prefilled Syringes
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United Kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest Of Europe
7.4.3 Asia-Pacific
7.4.3.1 China
7.4.3.2 Japan
7.4.3.3 India
7.4.3.4 Australia & New Zealand
7.4.3.5 South Korea
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa
7.4.4.1 GCC
7.4.4.2 South Africa
7.4.4.3 Rest of the Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Becton, Dickinson and Company
9.2 Gerresheimer AG
9.3 Haselmeier AG
9.4 Medtronic
9.5 NIPRO
9.6 Scandinavian Health Limited (SHL Group)
9.7 SCHOTT
9.8 Stevanato Group
9.9 TERUMO CORPORATION
9.10 Unilife Corporation
*List Not Exhaustive
10. Future Outlook of the Market